Huilei E. Miao
National Cancer Center/National Clinical Research Center For Cancer/Cancer Hospital Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
In vivo CAR-T: a paradigm shift in adoptive cell therapy from bench to beside.
Journal: Science bulletin
Published: February 15, 2026
CAR-NK cell therapy for hematologic malignancies: advances, challenges and optimization strategies.
Journal: Molecular cancer
Published: December 30, 2025
Recent advances in universal chimeric antigen receptor T cell therapy.
Journal: Journal of hematology & oncology
Published: June 03, 2025
Challenging go/no-go decision scenarios and design recommendations in phase II oncology trials.
Journal: Journal of the National Cancer Center
Published: March 12, 2025
Natural killer cell therapy: the key to tackle the bottleneck of cell therapies against solid tumor?
Natural killer cell therapy: the key to tackle the bottleneck of cell therapies against solid tumor?
Journal: Science bulletin
Published: January 16, 2025
Reflections and insights into the evolution of restrictive eligibility criteria for cancer clinical trials in China and beyond.
Journal: Cancer communications (London, England)
Published: November 24, 2024
Bridging the gap: unlocking the potential of emerging drug therapies for brain metastasis.
Journal: Brain : a journal of neurology
Published: May 14, 2024
Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 23, 2024
Exosome-based anticancer vaccines: From Bench to bedside.
Journal: Cancer letters
Published: March 14, 2024
Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world data.
Journal: Thoracic cancer
Published: February 04, 2024
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges.
Journal: The Lancet regional health. Western Pacific
Published: August 01, 2022
Drug conjugate-based anticancer therapy - Current status and perspectives.
Journal: Cancer letters
Published: June 27, 2022
Last Updated: 09/26/2026